Liu, Mingen

University of Pennsylvania

1 paper on CoChatORCID 0009-0000-0790-0456

Most cited papers

Verified
Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine / nab-paclitaxel for the treatment of patients with metastatic pancreas cancer
Bahary, N., Wang-Gillam, A., Haraldsdottir, S., Somer, B. G., Lee, J. S., O'Rourke, M. A., Nayak-Kapoor, A., Beatty, G. L., Liu, M., Delman, D., et al. (2018) · Journal of Clinical Oncology
Pancreatic and Hepatic Oncology ResearchCancer Immunotherapy and Biomarkers
Cited by 39

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free